logo

For the Inventor, By the Inventor

Valencia, CA, United States of America

Mark Hokenson

This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Mannkind Corporation. Active years: 2010-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Hokenson. Retrieved from https://idiyas.com/inventor/mark-hokenson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 126(Granted Patents)


Location History:

  • Valencia, CA (US) (2010 - 2016)
  • Camarillo, CA (US) (2018 - 2021)

Company Filing History:

goldMedal7 out of 286 
 
Mannkind Corporation
 patents

Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 11103459 - Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces (2021-08-31),
2. 10143655 - Method of drug formulation (2018-12-04),
3. 9446001 - Increasing drug affinity for crystalline microparticle surfaces (2016-09-20),
4. 9089497 - Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces (2015-07-28),
5. 9066881 - Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces (2015-06-30),
6. 8420604 - Method of drug formulation of compositions comprising crystalline microparticle surfaces (2013-04-16),
7. 7803404 - Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces (2010-09-28),

Title: Mark Hokenson: Innovator in Drug Formulation

Introduction

Mark Hokenson is a notable inventor based in Valencia, CA (US). He has made significant contributions to the field of drug formulation, holding a total of 7 patents. His work focuses on enhancing the efficacy of active agents in pharmaceutical applications.

Latest Patents

Hokenson's latest patents include a method of drug formulation that promotes the adsorption of active agents to crystalline microparticle surfaces. This innovative approach modifies the structural properties of the active agent to facilitate favorable association with the microparticle. His work in this area aims to improve the delivery and effectiveness of medications.

Career Highlights

Mark Hokenson is currently associated with Mannkind Corporation, where he continues to develop groundbreaking methods in drug formulation. His expertise and dedication to innovation have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Hokenson collaborates with various professionals in his field, including his coworker Keith A Oberg. Their combined efforts contribute to advancing drug formulation techniques and enhancing therapeutic outcomes.

Conclusion

Mark Hokenson's contributions to drug formulation through his innovative patents and collaborations highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in medication delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…